tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
US Market

Protagenic Therapeutics (PTIX) Ownership - Who Owns Protagenic Therapeutics?

Compare
63 Followers

Protagenic Therapeutics (PTIX) Ownership Overview

6.29%12.77%0.24%5.43%81.79%
6.29%
Insiders
0.24% Other Institutional Investors
5.43% ETFs
81.79% Public Companies and
Individual Investors
The ownership structure of Protagenic Therapeutics (PTIX) stock is a mix of institutional, retail, and individual investors. Approximately 18.44% of the company’s stock is owned by Institutional Investors, 6.29% is owned by Insiders, and 81.79% is owned by Public Companies and Individual Investors.
The ownership structure of Protagenic Therapeutics (PTIX) stock is a mix of institutional, retail, and individual investors. Approximately 13.01% of the company’s stock is owned by Institutional Investors, 6.29% is owned by Insiders, and 5.43% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
43,229Institution7.34%130,984
410,000Insider5.66%113,160
31,996Institution5.43%96,948
31,996Institution5.43%96,948
45,815Insider0.63%12,645

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
43,229Institution7.34%130,984
31,996Institution5.43%96,948

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
31,996Institution5.43%7,167

FAQ

Who Owns Protagenic Therapeutics (PTIX)?
According to the latest TipRanks data, approximately 0.24% of the company's stock is held by institutional investors, 6.29% is held by insiders, and 81.79% is held by retail investors.
    What percentage of Protagenic Therapeutics (PTIX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.24% of Protagenic Therapeutics (PTIX) stock is held by institutional investors.
      What percentage of Protagenic Therapeutics (PTIX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 81.79% of Protagenic Therapeutics (PTIX) stock is held by retail investors.
        Who owns the most shares of Protagenic Therapeutics (PTIX)?
        Fidelity Concord Street Trust owns the most shares of Protagenic Therapeutics (PTIX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis